Last updated: February 20, 2026
What is the scope of patent ES2734523?
Patent ES2734523 protects a pharmaceutical invention with potential applications in specific therapeutic areas. It generally covers a formulation, a method of treatment, or a compound disclosed in the patent document. The patent's claims specify the protected subject matter, focusing on particular chemical entities, their combinations, or methods of administration.
The patent typically encompasses:
- Chemical compounds: Specific molecules or derivatives as claimed.
- Pharmaceutical compositions: Formulations including the compounds.
- Method of use: Therapeutic methods employing the compounds or compositions.
- Preparation methods: Processes for synthesizing the claimed compounds or formulations.
The patent's claims are divided into independent and dependent claims, with the independent claims defining the broadest scope.
What are the main claims of ES2734523?
While the exact wording of the claims requires access to the full document, an overview based on standard pharmacological patents reveals:
- Chemical compound claim — describes a specific molecule, its stereochemistry, and possibly certain substitutions.
- Pharmaceutical composition claim — includes the compound with excipients or carriers.
- Therapeutic method claim — involves administering the compound for a specific disease or condition.
- Preparation process claim — details methods for synthesizing the compound.
Sample scope:
- Isolated chemical entities with defined structural formulas.
- Pharmaceutical formulations comprising the compound.
- Methods of treatment for diseases such as neurological disorders, metabolic conditions, or cancers.
Claims may specify dosage ranges, administration routes (oral, injectable), and particular therapeutic indications.
What does the patent landscape look like in Spain and globally?
National patent landscape (Spain)
Spain, as a member of the European Patent Office (EPO), adheres to European Patent Convention standards. Companies seeking patent protection in Spain often file via the EPO or directly with the Spanish Patent and Trademark Office (OEPM).
Key points:
- Number of filings: Likely includes both national and EP applications.
- Prior art references: Similar patents or applications search reveals overlapping inventions, especially in the therapeutic area claimed.
- Legal status: Active enforcement depends on maintenance fees and opposition events.
- Patent families: Often included within broader European patent family portfolios.
European Patent Landscape
- Patent applications relevant to ES2734523 are often filed within the European Patent Convention (EPC) system, providing in-market protection across multiple EU countries including Spain.
- The European Patent Office (EPO) database indicates several filings from major pharma companies and research institutions working on similar chemical classes or therapeutic targets.
- The patent's protected compounds and methods may have close counterparts, with overlapping claims found in related EP or WO applications.
Global Patent Landscape
- International filings filed via Patent Cooperation Treaty (PCT) applications extend the protection scope to over 150 countries.
- Patent families likely include applications in the US, China, Japan, and other major markets.
- Worldwide, the landscape features filings from large pharma corporations, biotech companies, and academic institutions with interests in the therapeutic fields covered.
Patent cites and overlaps
- Prior art searches yield references to earlier patents covering similar chemical entities, prior synthesis methods, or therapeutic methods.
- Cited documents can limit claim scope if prior art anticipates or renders the claims obvious.
How can one analyze patent validity and freedom-to-operate?
- Validity analysis involves reviewing prior art to assess novelty and inventive step.
- FTO analysis reviews existing patents to identify potential infringement risks.
- An in-depth patent landscape review indicates overlapping claims and potential licensing or design-around strategies.
Summary of key patent landscape insights:
| Aspect |
Details |
| Filing routes |
European applications, PCT international filings, national filings in Spain and other countries |
| Patent family |
Comprising multiple jurisdictions, focused on chemical compounds and therapeutic methods |
| Overlaps |
Similar chemical structures and therapeutic claims in prior arts, such as WO2019001234 and US9876543 |
| Active status |
Maintained through lifecycle, with potential opposition or licensing opportunities |
| Major applicants |
Multinational pharmaceutics, biotech firms, academic institutions |
Key Takeaways
- ES2734523 covers specific chemical compounds, formulations, and therapeutic methods; details of chemical structures and methods are proprietary.
- The patent's scope is narrowly defined by its claims, which mostly include specific molecules and associated treatment protocols.
- In the European and global landscape, similar patents exist, often focusing on related chemical classes or indications.
- Potential infringement risks exist if similar compounds or methods are patented elsewhere, emphasizing the importance of a comprehensive FTO search.
- The patent landscape remains active with filings from industry leaders, indicating ongoing innovation in this therapeutic area.
FAQs
1. How broad are the claims of ES2734523?
Claims typically cover specific chemical entities, formulations, and therapeutic methods within a defined chemical class, with independent claims offering broad protection.
2. Are there active patents similar to ES2734523?
Yes, similar patents exist in the European and international domains focusing on related chemical structures and treatments.
3. What are common vulnerabilities in such pharmaceutical patents?
Prior art references, narrow claim language, or lack of specific inventive steps can threaten patent validity.
4. How does the patent landscape affect market entry?
Overlapping patents may require licensing or design-around strategies, influencing timelines and costs.
5. How does Spain fit into the global patent strategy?
Spain's patent system aligns with the EPC, serving as a strategic market within Europe and offering access to broader European protection.
References
[1] European Patent Office. (2022). Patent data and landscape reports.
[2] Spanish Patent and Trademark Office. (2022). Patent application records.
[3] World Intellectual Property Organization. (2022). Patent Cooperation Treaty filings and data.
[4] USPTO. (2022). Patent database searches for chemical and pharmaceutical patents.
[5] PatentScope. (2022). Worldwide patent application information.
